{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:31:33Z","timestamp":1793655093411,"version":"4.5.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ygyno.2019.03.097","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T08:13:49Z","timestamp":1557908029000},"page":"124-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer"],"prefix":"10.1016","volume":"154","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6873-7832","authenticated-orcid":false,"given":"Casper","family":"Reijnen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi V.N.","family":"K\u00fcsters-Vandevelde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens F.","family":"Prinsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon F.A.G.","family":"Massuger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc P.M.L.","family":"Snijders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kommoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Y.","family":"Brucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice S.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"McAlpine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.A.","family":"Pijnenborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2019.03.097_bb0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00412-015-0514-0","article-title":"New insights into the mechanism of DNA mismatch repair","volume":"124","author":"Reyes","year":"2015","journal-title":"Chromosoma"},{"key":"10.1016\/j.ygyno.2019.03.097_bb0010","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ygyno.2018.08.020","article-title":"Does MMR status in endometrial cancer influence response to adjuvant therapy?","volume":"151","author":"Kim","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.097_bb0015","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/IGC.0000000000001343","article-title":"Endometrial Cancer Presentation and Outcomes Based on Mismatch Repair Protein Expression From a Population-Based Study","volume":"28","author":"Pina","year":"2018","journal-title":"Int J Gynecol Cancer."},{"key":"10.1016\/j.ygyno.2019.03.097_bb0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.ygyno.2019.03.097_bb0025","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.097_bb0030","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1200\/JCO.2016.67.8722","article-title":"Clinicopathologic significance of mismatch repair defects in endometrial cancer: an NRG oncology\/gynecologic oncology group study","volume":"34","author":"McMeekin","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.097_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research N","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2019.03.097_bb0040","doi-asserted-by":"crossref","unstructured":"Stelloo E, Bosse T, Nout RA, MacKay HJ, Church DN, Nijman HW, et al. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative. Mod. Pathol.. 2015; 28: 836\u201344.","DOI":"10.1038\/modpathol.2015.43"},{"key":"10.1016\/j.ygyno.2019.03.097_bb0045","doi-asserted-by":"crossref","unstructured":"Stelloo E, Nout RA, Osse EM, Jurgenliemk-Schulz IJ, Jobsen JJ, Lutgens LC, et al. Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts. Clin. Cancer Res.. 2016; 22: 4215\u201324.","DOI":"10.1158\/1078-0432.CCR-15-2878"},{"key":"10.1016\/j.ygyno.2019.03.097_bb0050","doi-asserted-by":"crossref","unstructured":"van Gool IC, Eggink FA, Freeman-Mills L, Stelloo E, Marchi E, de Bruyn M, et al. POLE proofreading mutations elicit an antitumor immune response in endometrial cancer. Clin. Cancer Res.. 2015; 21: 3347\u201355.","DOI":"10.1158\/1078-0432.CCR-15-0057"},{"key":"10.1016\/j.ygyno.2019.03.097_bb0055","doi-asserted-by":"crossref","unstructured":"Talhouk A, McConechy MK, Leung S, Yang W, Lum A, Senz J, et al. Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer. Cancer. 2017; 123: 802\u201313.","DOI":"10.1002\/cncr.30496"},{"key":"10.1016\/j.ygyno.2019.03.097_bb0060","doi-asserted-by":"crossref","unstructured":"Shikama A, Minaguchi T, Matsumoto K, Akiyama-Abe A, Nakamura Y, Michikami H, et al. Clinicopathologic implications of DNA mismatch repair status in endometrial carcinomas. Gynecol. Oncol.. 2016; 140: 226\u201333.","DOI":"10.1016\/j.ygyno.2015.11.032"},{"key":"10.1016\/j.ygyno.2019.03.097_bb0065","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/sj.onc.1206254","article-title":"The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase","volume":"22","author":"Franchitto","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2019.03.097_bb0070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/138920209788488544","article-title":"Involvement of nucleotide excision and mismatch repair mechanisms in double strand break repair","volume":"10","author":"Zhang","year":"2009","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.ygyno.2019.03.097_bb0075","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.1038\/sj.onc.1206893","article-title":"Differential involvement of the hMRE11\/hRAD50\/NBS1 complex, BRCA1 and MLH1 in NF-kappaB activation by camptothecin and X-ray","volume":"22","author":"Habraken","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2019.03.097_bb0080","doi-asserted-by":"crossref","unstructured":"Resnick KE, Frankel WL, Morrison CD, Fowler JM, Copeland LJ, Stephens J, et al. Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancer. Gynecol. Oncol.. 2010; 117: 234\u20138.","DOI":"10.1016\/j.ygyno.2009.12.028"},{"key":"10.1016\/j.ygyno.2019.03.097_bb0085","unstructured":"Colombo N, Creutzberg C, Amant F, Bosse T, Gonzalez-Martin A, Ledermann J, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Ann. Oncol.. 2016; 27: 16\u201341."},{"key":"10.1016\/j.ygyno.2019.03.097_bb0090","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ygyno.2014.06.003","article-title":"Endometrial cancer: a review and current management strategies: part II","volume":"134","author":"Group SGOCPECW","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.097_bb0095","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/jnci\/djs374","article-title":"Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis","volume":"104","author":"Kong","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2019.03.097_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001216","article-title":"Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration","volume":"9","author":"Altman","year":"2012","journal-title":"PLoS Med."},{"key":"10.1016\/j.ygyno.2019.03.097_bb0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/annonc\/mdw542","article-title":"Practical guidance for mismatch repair-deficiency testing in endometrial cancer","volume":"28","author":"Stelloo","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.097_bb0110","doi-asserted-by":"crossref","unstructured":"McConechy MK, Talhouk A, Li-Chang HH, Leung S, Huntsman DG, Gilks CB, et al. Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas. Gynecol. Oncol.. 2015; 137: 306\u201310.","DOI":"10.1016\/j.ygyno.2015.01.541"},{"key":"10.1016\/j.ygyno.2019.03.097_bb0115","doi-asserted-by":"crossref","unstructured":"Nout RA, Smit VT, Putter H, Jurgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet. 2010; 375: 816\u201323.","DOI":"10.1016\/S0140-6736(09)62163-2"},{"key":"10.1016\/j.ygyno.2019.03.097_bb0120","doi-asserted-by":"crossref","unstructured":"Cosgrove CM, Tritchler DL, Cohn DE, Mutch DG, Rush CM, Lankes HA, et al. An NRG Oncology\/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer. Gynecol. Oncol.. 2018; 148: 174\u201380.","DOI":"10.1016\/j.ygyno.2017.10.037"},{"key":"10.1016\/j.ygyno.2019.03.097_bb0125","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/cncr.31901","article-title":"Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: a prognostic biomarker","volume":"125","author":"Backes","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2019.03.097_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4132\/KoreanJPathol.2013.47.1.1","article-title":"Radiotherapy response in microsatellite instability related rectal cancer","volume":"47","author":"Shin","year":"2013","journal-title":"Korean J. Pathol."},{"key":"10.1016\/j.ygyno.2019.03.097_bb0135","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1073\/pnas.0407069102","article-title":"Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements","volume":"102","author":"Chen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2019.03.097_bb0140","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/sj.cdd.4401843","article-title":"Signals from within: the DNA-damage-induced NF-kappaB response","volume":"13","author":"Janssens","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ygyno.2019.03.097_bb0145","doi-asserted-by":"crossref","unstructured":"Westdorp H, Fennemann FL, Weren RD, Bisseling TM, Ligtenberg MJ, Figdor CG, et al. Opportunities for immunotherapy in microsatellite instable colorectal cancer. Cancer Immunol. Immunother.. 2016; 65: 1249\u201359.","DOI":"10.1007\/s00262-016-1832-7"},{"key":"10.1016\/j.ygyno.2019.03.097_bb0150","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1158\/1078-0432.CCR-16-0037","article-title":"Toward precision radiotherapy for use with immune checkpoint blockers","volume":"24","author":"Vanpouille-Box","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2019.03.097_bb0155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40425-016-0156-7","article-title":"Current clinical trials testing the combination of immunotherapy with radiotherapy","volume":"4","author":"Kang","year":"2016","journal-title":"J. Immunother. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819302707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819302707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:46:14Z","timestamp":1758771974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819302707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0090825819302707"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.03.097","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.03.097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}